Prevalence of Anosmia & Ageusia in confirmed COVID-19 patients at teaching hospitals of District Bannu and Swat, Pakistan.

Keywords: COVID-19, Anosmia, Ageusia, Olfactory Dysfunction, Gustatory Dysfunction.


Background: Recent evidence suggests olfactory and gustatory sensory deficits among Coronavirus Disease 2019 (COVID-19) patients. It is important to assess the occurrence of anosmia and ageusia among infected individuals as it may be the potential symptom and assist in controlling the viral load. The objective of the present study was to determine the prevalence of ageusia and anosmia among COVID-19 patients admitted to the teaching hospitals of District Bannu and Swat-Pakistan.

Methodology: This retrospective cohort study was conducted between April to November 2020. A total of 100 confirmed COVID-19 cases, tested through polymerase chain reaction (PCR), were included in the study. Data including gender, age, smoking status, recent travelling history, nasal and paranasal disorder (NPND) history and COVID-19 severity were obtained from the patients’ records. The symptomatology, including frequency of anosmia and ageusia was recorded.

Results: Out of 100 patients, 43.75% of patients had anosmia and 31.25% had ageusia, while 68% of patients were presented without olfactory and gustatory dysfunction. Most of the enrolled patients had no recent travel history (91.46%) and none of them were asymptomatic. Moreover, 88% of patients with a previous history of NPND did not have olfactory and gustatory dysfunction. Various characteristics features, including recent travel history, smoking, gender and disease severity, were significantly associated with anosmia and ageusia.

Conclusion: The COVID-19 patients were exclusively suffering from ageusia and anosmia. It can be concluded that amongst asymptomatic-to-mild disease severity patients, the existence of smell and taste might be an important differential demonstration for the apprehension and analysis of COVID-19.


Download data is not yet available.


1. Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nature Med. 2004; 10(12): S88-S97.
2. Syed I, Shamim N, Zaidi S. Past and current Coronavirus outbreaks; Focusing on Coronavirus Disease 2019 in comparison with Severe Acute Respiratory Syndrome and Middle East Respiratory Syndrome. IJEHSR.2020;8(3):159-170.
3. Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New Eng J Med. 2012; 367(19): 1814-1820.
4. Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Inf Disease. 2020; 91: 264-266.
5. Lu H, Stratton CW, Tang YW. Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle. J Med Virol. 2020; 92(4): 401-402.
How to Cite
Iqbal, M., Khan, S. F., Khan, S., & Ahmad, W. (2021). Prevalence of Anosmia & Ageusia in confirmed COVID-19 patients at teaching hospitals of District Bannu and Swat, Pakistan. International Journal of Endorsing Health Science Research (IJEHSR), 9(2), 217-222.